India-Malta Bilateral Trade Analysis 2023

Complete trade statistics: $320.90M total volume •India surplus: $320.90M

IndiaMalta

$320.90M

Exports (2023)

MaltaIndia

$0

Imports (2023)

Trade Balance

$320.90M

Surplus for India

Total Trade

$320.90M

Combined Volume

Trade Flow Visualization

Direct trade relationship between India and Malta. Green line shows exports from India, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the India-Malta commercial relationship and competitive positioning in global markets.

IndiaMalta Exports

$320.90M
2023 Total

Export Market Intelligence

Product Diversity:
Specialized Focus
Market Share:
49.6% top product
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$159.30M
49.6% of exports
2Petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils
$39.37M
12.3% of exports
3Aromatic hydrocarbon mixtures: n.e.c. in heading no. 2707, of which 65% or more by volume (including losses) distils at 250 degrees Celsius by the ISO 3405 method (equivalent to the ASTM D 86 method)
$19.57M
6.1% of exports
4Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale
$19.33M
6.0% of exports
5Tankers
$16.50M
5.1% of exports

🎯 Strategic Export Focus

India's export portfolio to Malta demonstrates strategic specialization, with medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale representing a key competitive advantage in this bilateral market.

MaltaIndia Imports

$0
2023 Total

Import Dependency Profile

Supply Diversity:
Concentrated
Critical Imports:
Infinity% concentration
1Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (INN) and methyprylon (INN)
$12.13M
Infinity% of imports
2Electronic integrated circuits: processors and controllers, whether or not combined with memories, converters, logic circuits, amplifiers, clock and timing circuits, or other circuits
$5.71M
Infinity% of imports
3Machines and mechanical appliances: having individual functions, n.e.c. or included in this chapter
$4.88M
Infinity% of imports
4Heterocyclic compounds: n.e.c. in headings no. 2933
$3.07M
Infinity% of imports
5Steroidal hormones, their derivatives and structural analogues: oestrogens and progestogens
$2.01M
Infinity% of imports

📦 Import Strategy Analysis

India's import pattern from Malta reveals significant dependencyin heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn), highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

🏆

Market Leadership

India demonstrates competitive strength in exportingmedicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale to Malta, leveraging comparative advantages.

Export Leader in 5+ Categories
🔄

Trade Complementarity

The bilateral relationship showsmoderatecomplementarity, with each country specializing in different sectors.

Specialized Exchange
📈

Growth Potential

The $320.90M trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Significant Partnership

Executive Summary: India-Malta Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $320.90 millionrepresenting a significant bilateral economic relationship
  • Trade Balance: India maintains a surplus of $320.90 million
  • Export Focus: India's primary exports include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils, aromatic hydrocarbon mixtures: n.e.c. in heading no. 2707, of which 65% or more by volume (including losses) distils at 250 degrees celsius by the iso 3405 method (equivalent to the astm d 86 method)
  • Import Dependencies: Key imports from Malta include heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn), electronic integrated circuits: processors and controllers, whether or not combined with memories, converters, logic circuits, amplifiers, clock and timing circuits, or other circuits, machines and mechanical appliances: having individual functions, n.e.c. or included in this chapter

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationConcentrated
Trade Balance HealthImbalanced

📈 Market Position: This bilateral trade relationship represents an important regional trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $320.90M represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with India leveraging its comparative advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

India's specialization in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail salecomplements Malta's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn).

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $320.90M bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationMedium
Market DependencyHigh
🔮

Trade Relationship Outlook

The $320.90M bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

💰

Trade Volume Impact

The $320.90 million bilateral trade volume represents a important trade relationshipfor both economies.

Economic Significance: Moderate
🏭

Industrial Integration

Trade flows in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale and heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn) demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Specialized
⚖️

Trade Balance Effects

India's trade surplus of $320.90 million strengthens its overall economic position in this bilateral relationship.

Balance Impact: Export Advantage

Strategic Future Outlook

🚀Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils present expansion opportunities.
Market Diversification
Beyond current focus on heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn), new product categories offer potential for trade expansion.

⚠️Risk Factors

Supply Chain Vulnerabilities
High trade imbalance may create supply chain risks
Market Competition
Global competition in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale may affect future market positioning.

🎯Strategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between India and Malta represents a total trade volume of $320.90 million in 2023. This partnership demonstrates a favorable trade balance for India, with exports exceeding importsby $320.90 million.

Export Strengths

India's exports to Malta total $320.90 million, with competitive advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, representing $159.30M or49.6% of bilateral exports.

Import Dependencies

Imports from Malta amount to $0.00, highlighting economic interdependence in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn), with Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (INN) and methyprylon (INN) comprisingInfinity% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade surplus indicates India's competitive position in this bilateral relationship. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between India and Malta in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) • Last Updated: January 2025 • Coverage: 1995-2023